Skip to main content
. 2015 Jun 3;10(6):e0128965. doi: 10.1371/journal.pone.0128965

Table 3. Genotype and Allele distributions in patients with valvular calcification and control participants.

Han Uygur Kazak
Variant Valvular calcification(%) control(%) P value Valvular calcification(%) control(%) P value Valvular calcification(%) control(%) P value
rs1800871
Genotype
TT 107(55.2) 167(40.6) 13(22) 27(20.3) 31(38.3) 48(25.7)
CC 20(10.3) 59(14.4) 20(33.9) 39(29.3) 13(16) 40(21.4)
CT 67(34.5) 185(45) 0.004 26(44.1) 67(50.4) 0.714 37(45.7) 99(52.9) 0.108
Dominant model
CC 20(10.3) 59(14.4) 20(33.9) 39(29.3) 13(16) 40(21.4)
CT+TT 174(89.7) 352(85.6) 0.168 39(66.1) 94(70.7) 0.526 68(84) 147(78.6) 0.313
Recessive model
TT 107(55.2) 167(40.6) 13(22) 27(20.3) 31(38.3) 48(25.7)
CT+CC 87(44.8) 244(59.4) 0.001 46(78) 106(79.7) 0.785 50(61.7) 139(74.3) 0.038
Additive model
CT 67(34.5) 185(45) 26(44.1) 67(50.4) 37(45.7) 99(52.9)
CC+TT 127(65.5) 226(55) 0.015 33(55.9) 66(49.6) 0.42 44(54.3) 88(47.1) 0.275
Allele
C 107(27.6) 303(36.9) 66(55.9) 145(54.5) 63(38.9) 179(47.86)
T 281(72.4) 519(63.1) 0.001 52(44.1) 121(45.5) 0.796 99(61.1) 195(52.14) 0.055
rs1800872
genotype
CC 64(33) 63(15.3) 31(52.2) 46(34.6) 36(44.4) 55(29.4)
AA 77(39.7) 163(39.7) 10(16.9) 26(19.5) 18(22.2) 50(26.7)
AC 53(27.3) 185(45) 0 18(30.5) 61(45.9) 0.056 27(33.3) 82(43.9) 0.056
Dominant model
CC 64(33) 63(15.3) 31(52.2) 46(34.6) 36(44.4) 55(29.4)
AC+AA 130(67) 348(84.7) 0 28(47.5) 87(65.4) 0.019 45(55.6) 132(70.6) 0.017
Recessive model
AA 77(39.7) 163(39.7) 10(16.9) 26(19.5) 18(22.2) 50(26.7)
AC+CC 117(60.3) 248(60.3) 0.994 49(83.) 107(80.5) 0.67 63(77.8) 137(73.3) 0.435
Additive model
AC 53(27.3) 185(45) 18((30.5) 61(45.9) 27(33.3) 82(43.9)
AA+CC 141(72.7) 226(55) 0 41(69.5) 72(54.1) 0.046 54(66.7) 105(56.1) 0.107
Allele
C 181(46.6) 311(37.8) 80(67.8) 153(57.5) 99(61.1) 192(51.3)
A 207(53.4) 511(62.2) 0.004 38(32.2) 113(42.5) 0.057 63(38.9) 182(48.7) 0.037